UK markets closed

PharmaSGP Holding SE (PSGD.XC)

Cboe UK - Cboe UK Real-time price. Currency in EUR
Add to watchlist
22.30-6.50 (-22.57%)
At close: 04:28PM BST
Currency in EUR

Valuation measures4

Market cap (intra-day) 273.38M
Enterprise value 227.91M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.03
52-week change 3N/A
S&P500 52-week change 322.55%
52-week high 328.40
52-week low 328.40
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 82.22M
% held by insiders 181.40%
% held by institutions 110.19%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 31.36
Trailing annual dividend yield 34.72%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 427 Jun 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 16.88%
Operating margin (ttm)20.94%

Management effectiveness

Return on assets (ttm)11.99%
Return on equity (ttm)46.42%

Income statement

Revenue (ttm)107.29M
Revenue per share (ttm)8.92
Quarterly revenue growth (yoy)25.80%
Gross profit (ttm)N/A
EBITDA 35.02M
Net income avi to common (ttm)18.11M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)60.20%

Balance sheet

Total cash (mrq)46.27M
Total cash per share (mrq)3.86
Total debt (mrq)74.02M
Total debt/equity (mrq)165.71%
Current ratio (mrq)2.53
Book value per share (mrq)3.72

Cash flow statement

Operating cash flow (ttm)27.64M
Levered free cash flow (ttm)18.23M